Who’s in the Room? Meet the Clinicians, Operators and Advocates Joining the London Cannabis Health Symposium
Who will you meet at Cannabis Health Symposium London next week?
The latest cannabis health, science and regulatory news from the UK and Europe.
Who will you meet at Cannabis Health Symposium London next week?
Looking for medical cannabis conferences and industry events? Here are the upcoming UK dates, who they’re for and where to book.
Experts at the first Cannabis Health Symposium in Germany urged the industry to fund research into women’s pain, with an endometriosis specialist outlining plans for a new cannabis study and appealing for €300,000 for research.
Last week, Cannabis Health Symposium hosted its first event in Frankfurt, bringing together healthcare professionals, researchers, policymakers and industry operators.
Could medical cannabis help with MS, Parkinson’s, epilepsy or nerve pain? We explore what the research shows and where questions remain…
This week, the Cannabis Health Symposium came to Germany for the first time, bringing healthcare professionals, researchers, policymakers and industry operators to Mainhaus in Frankfurt on Wednesday, 4 November. Coming […]
BvCW president Dirk Heitepriem will speak in Frankfurt today about how lessons from across Europe could improve medical cannabis prescribing and patient care in Germany.
Joining us on Wednesday 4 November? Here is your guide to everything you need to know…
Lessons from medical cannabis markets across Europe will be explored at this week’s Cannabis Health Symposium in Frankfurt, with a focus on improving prescribing and patient care in Germany.
Copeia co-founder Garvin Hirt will join researchers in Frankfurt to discuss how politicians and doctors should make cannabis decisions when evidence is incomplete.
Has online prescribing improved medical cannabis care in Germany? Bertan Türemis will join a Frankfurt debate on telemedicine, prescribing standards and patient safety.
Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products.
Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients.
Upcoming Symposium
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
26 November 2026
London · Conway Hall